21 – 30 of 327
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management : A PIONEER Analysis Based on Big Data
2023) In European Urology(
- Contribution to journal › Article
- 2022
-
Mark
Re : Performance of a Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography–derived Risk-stratification Tool for High-risk and Very High-risk Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Nuclear expression of pSTAT3Tyr705 and pSTAT3Ser727 in the stromal compartment of localized hormone-naïve prostate cancer
(
- Contribution to journal › Article
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
(
- Contribution to journal › Article
-
Mark
Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer
(
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
(
- Contribution to journal › Article
-
Mark
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Increasing rates of urinary- and bloodstream infections following transrectal prostate biopsy in South Sweden
(
- Contribution to journal › Article
-
Mark
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
(
- Contribution to journal › Article
-
Mark
Detection of lymph node metastases in patients with prostate cancer : Comparing conventional and digital [18F]-fluorocholine PET-CT using histopathology as a reference
(
- Contribution to journal › Article